男生如果明白 发表于 2025-3-25 06:05:43
978-3-031-31696-8Springer Nature Switzerland AG 20231FAWN 发表于 2025-3-25 08:28:14
http://reply.papertrans.cn/32/3195/319490/319490_22.png调整校对 发表于 2025-3-25 12:53:47
http://reply.papertrans.cn/32/3195/319490/319490_23.pngAspiration 发表于 2025-3-25 17:41:03
http://reply.papertrans.cn/32/3195/319490/319490_24.pngheterogeneous 发表于 2025-3-25 20:47:18
Liposomes and Lipid Nanoparticles as Peritoneal Drug Delivery Systems, short retention times, and poor bioavailability. The objectives of this chapter are to briefly review the features, classification, and applications of drug lipid nanoparticles..Liposomes and lipid nanoparticles can be used to deliver drugs to the peritoneum, allowing the targeted treatment of diseArthritis 发表于 2025-3-26 01:40:08
http://reply.papertrans.cn/32/3195/319490/319490_26.pngforager 发表于 2025-3-26 04:57:11
http://reply.papertrans.cn/32/3195/319490/319490_27.png失败主义者 发表于 2025-3-26 11:05:26
Drug Delivery Systems to the Peritoneum: Current Status and Future Perspectives,s. Future studies in the chapter mainly focus on improving the clinical relevance of the experiments, standardizing the experimental study setup, and improving their methodological quality and reporting.Dorsal 发表于 2025-3-26 15:11:59
Exploring the Intraperitoneal Route in a New Way for Preclinical Testing,his book chapter emphasizes on various aspects of IP drug delivery including biology of peritoneal cavity, factors affecting pharmacokinetics of drugs, systems used in IP drug delivery and animal models. This will open the new doors for successful treatment of IP disease conditions, provide clear su要塞 发表于 2025-3-26 18:45:53
http://reply.papertrans.cn/32/3195/319490/319490_30.png